HeyJaredPaul Talks Science
Welcome to "Paul Talks Science," a podcast that journeys into the ever-evolving realms of health, science, and innovation.
- Indexed episodes, last 90 days
- 4
- Latest publication
- Sep 21, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 9, 2026
Latest episodes
Inside the first human trial of a Bundibugyo Ebola vaccine (opens the original)
Read excerpt
Oxford researchers have begun the first-in-human trial of a vaccine against Bundibugyo Ebola virus. In this episode, Paul Adepoju speaks with Katrina Pollock, chief investigator of the trial at the Oxford Vaccine Group, about how the study is being run, what Phase 1 can and cannot tell us, the challenge of proving protection during an active outbreak, and what needs to happen before a vaccine can move into wider use.
35 New Cancer Machines, But Who Gets Treated? (opens the original)
Read excerpt
Nigeria is planning a major expansion of radiotherapy, with 35 additional linear accelerators expected to boost the country’s capacity to treat cancer. But buying the machines is only the beginning. In this episode of Paul Talks Science , I speak with Runcie C.W. Chidebe, Executive Director of Project PINK BLUE , about what radiotherapy access really looks like for patients in Nigeria and what must happen for this new investment to make a difference. We discuss why some radiotherapy machines and
First Nations Cancer Inequalities in Canada (opens the original)
Read excerpt
New research has revealed persistent inequalities in cancer outcomes among First Nations people in Ontario, Canada. The study found higher colon cancer incidence at younger ages and poorer survival after breast, cervical, and colon cancer diagnoses. Its publication coincides with Ontario’s decision to lower the starting age for colorectal cancer screening from 50 to 45, making more than one million additional people eligible. But earlier screening addresses only one part of the problem. For peop
South Africa’s Cancer Moonshot (opens the original)
Read excerpt
In this episode of Paul Talks Science , I explore South Africa’s cancer care crisis through the lens of the country’s first imPACT Review, an international assessment supported by the International Atomic Energy Agency, WHO and the International Agency for Research on Cancer. The episode builds on my newly published The Lancet Oncology news feature, “ South Africa’s first imPACT Review ”, which examines whether the review can help turn long-recognised cancer-care gaps into funded, measurable act
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.